Ganirelix Acetate Injection, Solution
Product Images NDC 68083-472

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ganirelix Acetate (NDC 68083-472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ganirelix-spl-carton-label (Ganirelix Spl Carton Label)

This is a description of Ganirelix Acetate Injection, which is packaged in a single-dose sterile prefilled syringe. It contains 250 meg/0.5 mL of ganirelix acetate and is intended for subcutaneous use only, with the needle provided. The product is manufactured by Gland Pharma Limited and is latex-free. The dosage and storage instructions are provided, as well as the pharmaceutical information and the manufacturer's details.*

FDA Label Image

Ganirelix-spl-structure (Ganirelix Spl Structure)

FDA Label Image

Ganirelix-spl-vial-label (Ganirelix Spl Vial Label)

This is a description of a medication called Ganirelix Acetate Injection. The medication is packaged in a single-dose sterile prefilled syringe with a 27-gauge by 1/2" needle. The dosage strength is 250 meg/0.5 mL and it is intended for subcutaneous use. The medication should be protected from light and any unused portion should be discarded. The medication is manufactured by Gland Pharma Limited in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.